FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification
ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
(U.S. FDA National Drug Code DataBase)
本数据库为美国药品NDC(国家药品编码)与药品说明书数据库,集成了U.S. National Drug Code(简称NDC,即美国国家药品编码)数据库,并收录了所有在美国上市的药品的说明书全文。查询结果药品商品名、专利药品、通用名、活性成分、剂型、规格、给药途径、上市日期、市场类别、上市厂家、包装信息以及药品说明书全文和PDF文档下载等。
本数据库每周更新,当前数据库最后更新时间:
包装NDC编码:输入完整的药品包装NDC编码(格式示例:85384-0005-1),可查询该特定包装药品的详细信息,精准查询。
正在查询药物信息,请稍候...
请检查查询条件是否正确,或稍后重试
                            ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
                            The 2024 New Drug Therapy Approvals report features drug approvals that CDER considers likely to have a significant impact on public health.
                            FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.